These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 32371472)

  • 1. SARS-CoV-2 and ORF3a: Nonsynonymous Mutations, Functional Domains, and Viral Pathogenesis.
    Issa E; Merhi G; Panossian B; Salloum T; Tokajian S
    mSystems; 2020 May; 5(3):. PubMed ID: 32371472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the Role of SARS-CoV-2 ORF3a in Viral Pathogenesis and COVID-19.
    Zhang J; Ejikemeuwa A; Gerzanich V; Nasr M; Tang Q; Simard JM; Zhao RY
    Front Microbiol; 2022; 13():854567. PubMed ID: 35356515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional alterations caused by mutations reflect evolutionary trends of SARS-CoV-2.
    Cheng L; Han X; Zhu Z; Qi C; Wang P; Zhang X
    Brief Bioinform; 2021 Mar; 22(2):1442-1450. PubMed ID: 33580783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic perspective of missense mutations of ORF3a protein of SARS-CoV-2.
    Hassan SS; Attrish D; Ghosh S; Choudhury PP; Roy B
    Virus Res; 2021 Jul; 300():198441. PubMed ID: 33940003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of the effects of the top 10 nonsynonymous variants from 30229 SARS-CoV-2 strains on their proteins.
    Sia BZ; Boon WX; Yap YY; Kumar S; Ng CH
    F1000Res; 2022; 11():9. PubMed ID: 35707000
    [No Abstract]   [Full Text] [Related]  

  • 6. The ion channel activity of the SARS-coronavirus 3a protein is linked to its pro-apoptotic function.
    Chan CM; Tsoi H; Chan WM; Zhai S; Wong CO; Yao X; Chan WY; Tsui SK; Chan HY
    Int J Biochem Cell Biol; 2009 Nov; 41(11):2232-9. PubMed ID: 19398035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of SARS-CoV-2 mutations on protein structures and intraviral protein-protein interactions.
    Wu S; Tian C; Liu P; Guo D; Zheng W; Huang X; Zhang Y; Liu L
    J Med Virol; 2021 Apr; 93(4):2132-2140. PubMed ID: 33090512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing genomic variants and mutations in SARS-CoV-2 proteins from Indian isolates.
    Das JK; Sengupta A; Choudhury PP; Roy S
    Gene Rep; 2021 Dec; 25():101044. PubMed ID: 33623833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ORF3a-Mediated Incomplete Autophagy Facilitates Severe Acute Respiratory Syndrome Coronavirus-2 Replication.
    Qu Y; Wang X; Zhu Y; Wang W; Wang Y; Hu G; Liu C; Li J; Ren S; Xiao MZX; Liu Z; Wang C; Fu J; Zhang Y; Li P; Zhang R; Liang Q
    Front Cell Dev Biol; 2021; 9():716208. PubMed ID: 34386498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations in Orf3a protein of SARS-CoV-2 alter its structure and function.
    Azad GK; Khan PK
    Biochem Biophys Rep; 2021 Jul; 26():100933. PubMed ID: 33527091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-Cov-2 ORF3a: Mutability and function.
    Bianchi M; Borsetti A; Ciccozzi M; Pascarella S
    Int J Biol Macromol; 2021 Feb; 170():820-826. PubMed ID: 33359807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome.
    Chen IY; Moriyama M; Chang MF; Ichinohe T
    Front Microbiol; 2019; 10():50. PubMed ID: 30761102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D155Y substitution of SARS-CoV-2 ORF3a weakens binding with Caveolin-1.
    Gupta S; Mallick D; Banerjee K; Mukherjee S; Sarkar S; Lee ST; Basuchowdhuri P; Jana SS
    Comput Struct Biotechnol J; 2022; 20():766-778. PubMed ID: 35126886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryo-EM structure of the SARS-CoV-2 3a ion channel in lipid nanodiscs.
    Kern DM; Sorum B; Mali SS; Hoel CM; Sridharan S; Remis JP; Toso DB; Kotecha A; Bautista DM; Brohawn SG
    bioRxiv; 2021 Jan; ():. PubMed ID: 32587976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Amino Acid Mutations Detection in Greek Patients Infected in the First Wave of the Pandemic.
    Vassilaki N; Papadimitriou K; Ioannidis A; Papandreou NC; Milona RS; Iconomidou VA; Chatzipanagiotou S
    Microorganisms; 2022 Jul; 10(7):. PubMed ID: 35889149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the YXXΦ Motifs of the SARS Coronaviruses 1 and 2 ORF3a Peptides by In Silico Analysis to Predict Novel Virus-Host Interactions.
    Kakkanas A; Karamichali E; Koufogeorgou EI; Kotsakis SD; Georgopoulou U; Foka P
    Biomolecules; 2022 Jul; 12(8):. PubMed ID: 36008946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the nucleotide substitutions in 62 SARS-CoV-2 sequences from Turkey.
    Demİr AB; Benvenuto D; AbacioĞlu H; Angeletti S; Ciccozzi M
    Turk J Biol; 2020; 44(3):178-184. PubMed ID: 32595354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exhaustive mutational analysis of severe acute respiratory syndrome coronavirus 2 ORF3a: An essential component in the pathogen's infectivity cycle.
    Benazraf A; Arkin IT
    Protein Sci; 2023 Jan; 32(1):e4528. PubMed ID: 36468608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells.
    Glinsky GV
    Biomedicines; 2020 May; 8(5):. PubMed ID: 32455629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variety of ORF3a shapes SARS-CoV-2 fitness through modulation of lipid droplet.
    Wang W; Qu Y; Wang X; Xiao MZX; Fu J; Chen L; Zheng Y; Liang Q
    J Med Virol; 2023 Mar; 95(3):e28630. PubMed ID: 36861654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.